Rigel Pharmaceuticals, Inc. (RIGL)
44.64
+0.70
(+1.59%)
USD |
NASDAQ |
Dec 24, 16:00
Rigel Pharmaceuticals Market Cap: 810.27M for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 963.92B |
| Catalyst Pharmaceuticals, Inc. | 3.005B |
| Amicus Therapeutics, Inc. | 4.397B |
| Perspective Therapeutics, Inc. | 208.89M |
| Nektar Therapeutics | 760.18M |
Market Cap Related Metrics
| PE Ratio | 7.240 |
| PS Ratio | 2.907 |
| PEG Ratio | 0.0026 |
| Price to Book Value | 6.890 |
| Price to Free Cash Flow | 12.03 |
| Price | 44.64 |
| Earnings Yield | 13.81% |
| PEGY Ratio | 0.0026 |
| Operating PE Ratio | 6.893 |
| Normalized PE Ratio | 7.240 |